Rheumatoid Arthritis Management Strategies: New Insights for Managed Care
Reserve your spot today for a Satellite Lunch Symposium
Rheumatoid Arthritis Management Strategies: New Insights for Managed Care

Jointly provided by Impact Education, LLC and Postgraduate Institute for Medicine.
Impact Education, LLC     Postgraduate Institute for Medicine
This activity is supported by an independent educational grant from AbbVie Inc.
Monday, October 22, 2018
11:00 AM - 12:30 PM
Orlando World Marriott Center
Room: Canary 3-4
Orlando, FL


Please note: No additional fee is required to attend this CME/CPE activity; however, registration to AMCP Nexus 2018 is required.
Held in conjunction with

  Hot Topics
  • Emerging RA treatment strategies and therapies
  • Aligning managed care RA treatment algorithms with recent clinical trial data
  • Care pathways as a cost management tool in RA
  Expert Faculty Presenters
James Kenney, Jr., RPh, MBA
Manager, Specialty and Pharmacy Contracts
Harvard Pilgrim Health Care
Robin Dore, MD
Clinical Professor of Medicine
David Geffen School of Medicine at UCLA
  Who Should Attend?

This activity is designed to meet the educational needs of managed care pharmacy directors, clinical pharmacists, quality directors, medical directors, members of the AMCP, and other managed health care professionals attending AMCP Nexus 2018.

  Statement of Need/Program Overview

A cure for rheumatoid arthritis (RA) remains elusive, but effective drugs are available to manage symptoms and minimize disease progression. In addition to medications, regular performance of self-management techniques, including physical activity, are known to reduce pain and disability. RA treatment goals include controlling pain and inflammation, achieving the lowest disease activity, and ultimately, remission. This symposium highlights opportunities for managed care and specialty pharmacy professionals to optimize the management of patients with RA by implementing and/or recommending evidence-based practice recommendations based on current clinical trial data.

  Educational Objectives

At the conclusion of this activity, participants should be able to demonstrate improved ability to:
  • Review recent insights into the pathophysiology of RA and emerging treatment strategies
  • Discuss the safety, efficacy, and attributes of emerging therapies
  • Align managed care RA treatment algorithms with recent clinical trial data
  • Employ specialty pharmacy and disease management services for RA patients
  • Describe care pathways and their application as a cost management tool in RA
  Agenda

Date and Time
Monday, October 22, 2018
11:00 AM - 12:30 PM
Orlando World Center Marriott
Room: Canary 3-4
Orlando, FL

11:00 AM Lunch and Registration
Pre-Activity Learning Assessment and Opening Comments/Overview
11:05 AM Clinical Update: Recent Insights for Optimal Treatment
Robin Dore, MD
11:35 AM Care Management Strategies to Improve Clinical and Economic Outcomes
James Kenney, Jr., RPh, MBA
11:55 AM Benefit Design and Specialty Pharmacy Services for Effective RA Management
James Kenney, Jr., RPh, MBA
12:15 PM Audience Q&A Session
12:25 PM Key Takeaways and Closing Comments; Post-Activity Assessment and Evaluation
12:30 PM Adjournment
  Accreditation Information
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and Impact Education, LLC. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education
The Postgraduate Institute for Medicine designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Pharmacy Education
Postgraduate Institute for Medicine designates this continuing education activity for 1.5 contact hours (0.15 CEUs) of the Accreditation Council for Pharmacy Education.

Universal Activity Number: JA4008162-9999-18-346-L01-P
Type of Activity: Application

Interprofessional Continuing Education
This activity was planned by and for the healthcare team, and learners will receive 2.0 Interprofessional Continuing Education (IPCE) credit for learning and change.

Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

Americans with Disabilities Act
♿ Event staff will be glad to assist you with any special needs (ie, physical, dietary, etc). Please contact Impact Education, LLC, prior to the live event at (215) 619-8812.

Fee Information
No additional fee is required to attend this CPE/CME activity.

Please note: No additional fee is required to attend this CME/CPE activity; however, registration to AMCP Nexus 2018 is required.

Pre-registration will close at 12:00 pm on October 21, 2018.
Walk-in registration will be available at the time of the program.
If you have any questions, please call (215) 619-8812 or email info@impactedu.net.